Viewing Study NCT04743869



Ignite Creation Date: 2024-05-06 @ 3:45 PM
Last Modification Date: 2024-10-26 @ 1:56 PM
Study NCT ID: NCT04743869
Status: UNKNOWN
Last Update Posted: 2021-02-08
First Post: 2021-02-03

Brief Title: Calcium Phosphate Versus PMMA Cement in Thoracolumbar Fractures
Sponsor: Medical University of Graz
Organization: Medical University of Graz

Study Overview

Official Title: Calcium Phosphate Versus PMMA Cement in Unstable Thoracolumbar Burst Fractures Treated With Dorsal Instrumentation in Patients 50 Years of Age Randomized Controlled Non-inferiority Trial Design
Status: UNKNOWN
Status Verified Date: 2021-02
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CaPvsPMMA
Brief Summary: Patients at the age of 50 or older presenting with thoracolumbar fractures including segments TH 6-L5 and A3A4 fractures according to the AO Spine fracture classification after the acute trauma and planned surgery within 3 weeks following trauma will be asked to participate in a randomized trial in which they will receive either Calciumphosphate CaP or Polymethylmethacrylate PMMA as part of a standardized treatment approach Regardless of the group patients are randomized to all participating patients undergo the same surgical procedure except for the preparation and administration of bone cement The study participation period for each patient is 1 year from the date of the surgery and includes 4 defined time points that include follow-up clinical visits for imaging and progress checks at 6 weeks 3 months 6 months and 12 months after surgery At each follow-up visit a combination of questionnaires and radiological imaging will be performed to assess general health status disability level and pain control as well as objective results of the surgery The main outcome measure will be the loss of correction rate that will be measured through the bi-segmental COBB angle presented in the CT-scan
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None